Clinical trial
Biological Therapy in Previously Treated Patients With Non-small Cell Lung…
NCT00003090 · Cancer Biotherapy Research Group, Other · Unknown status
Key facts
| NCT number | NCT00003090 |
|---|---|
| Title | Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer |
| Official title | Phase II Trial of Bolus Interleukin-2 in Previously Treated Lung Cancer |
| Lead sponsor | Cancer Biotherapy Research Group, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological |
| Interventions | aldesleukin |
| Enrollment | 30 |
| Start date | Jan 1, 1996 |
| First posted | Aug 2, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: